Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway

Chemoresistance is responsible for most colorectal cancer (CRC) related deaths. In this study, we found that dichloroacetate (DCA), a pyruvate dehydrogenase kinase (PDK) inhibitor, can be used as a sensitizer for oxaliplatin (L-OHP) chemoresistant CRC cells. The aim of this study was to explore the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Cancer
Autors principals: Liang, Yu, Zhu, Danxi, Zhu, Liming, Hou, Yichao, Hou, Lidan, Huang, Xin, Li, Linjing, Wang, Yu, Li, Lei, Zou, Huimin, Wu, Tianqi, Yao, Mengfei, Wang, Jianhua, Meng, Xiangjun
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2019
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856576/
https://ncbi.nlm.nih.gov/pubmed/31762813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34650
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars